𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone

✍ Scribed by G. Egerer; U. Hegenbart; H. Salwender; R. Haas; U. Hahn; J. Schmier; A. Ho; H. Goldschmidt

Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
120 KB
Volume
9
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination of interferon and dexamethas
Combination of interferon and dexamethasone in refractory multiple myeloma
✍ J. F. San Miguel; M. Moro; J. BladΓ©; L. Guerras; J. Hernandez; R. Jimenez-Galind πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 289 KB

The present pilot study was designed to analyse the efficacy and toxicity of the association of interferon (IFN) and dexamethasone (Dx) in 32 resistant and relapsed myeloma patients. Among the evaluable cases, 15 (68 per cent) responded to treatment (32 per cent achieved an objective respons4R-and 3

Combination chemotherapy of multiple mye
Combination chemotherapy of multiple myeloma with Alkeran, Cytoxan, vincristine, prednisone, and BCNU
✍ Burton J. Lee; George Sahakian; Bayard D. Clarkson; Irwin H. Krakoff πŸ“‚ Article πŸ“… 1974 πŸ› John Wiley and Sons 🌐 English βš– 537 KB

Thirty-six patients with myeloma have been treated with a combination drug protocol (M2) including Alkeran, Cytoxan, prednisone, BCNU, and vincristine. Thirty-two patients have been adequately treated and evaluated. Sixty percent have had excellent subjective and objective responses (I-A), An additi